AMG 557 in SLE Subjects with Active Lupus Arthritis

• Research type

  Research Study

• Full title

  A Randomised, Double-blind, Placebo-controlled, Multiple Dose, Parallel, Multiple Dose-Level Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Systemic Lupus Erythematosus (SLE) Subjects with Active Lupus Arthritis

• IRAS ID

  125277

• Contact name

  Caroline Gordon

• Contact email

  p.c.gordon@bham.ac.uk

• Sponsor organisation

  Amgen Ltd

• Eudract number

  2012-001053-56

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  13/WM/0208

• Date of REC Opinion

  26 Jul 2013

• REC opinion

  Favourable Opinion